136 related articles for article (PubMed ID: 27496455)
21. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
[TBL] [Abstract][Full Text] [Related]
22. HLA gene dosage effect on renal allograft survival.
Kim KH; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
Transplant Proc; 2015 Apr; 47(3):635-9. PubMed ID: 25891701
[TBL] [Abstract][Full Text] [Related]
23. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
24. Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation.
Bretagnol A; Halimi JM; Roland M; Barbet C; Machet L; Al Najjar A; Marlière JF; Badin J; Nivet H; Lebranchu Y; Büchler M
Transpl Int; 2010 Sep; 23(9):878-86. PubMed ID: 20230542
[TBL] [Abstract][Full Text] [Related]
25. Association of HLA mismatch and MTOR inhibitor regimens with malignancy and mortality after kidney transplantation.
Santos AH; Chen C; Leghrouz MA; Bueno EP; Lee JJ; Wen X
Transpl Immunol; 2021 Jun; 66():101391. PubMed ID: 33838299
[TBL] [Abstract][Full Text] [Related]
26. Perceptions of Risk of Developing Skin Cancer for Diverse Audiences: Enhancing Relevance of Sun Protection to Reduce the Risk.
Robinson JK; Friedewald J; Gordon EJ
J Cancer Educ; 2016 Mar; 31(1):153-7. PubMed ID: 26209181
[TBL] [Abstract][Full Text] [Related]
27. Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant Recipients.
Zavattaro E; Fava P; Veronese F; Cavaliere G; Ferrante D; Cantaluppi V; Ranghino A; Biancone L; Fierro MT; Savoia P
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31208110
[No Abstract] [Full Text] [Related]
28. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.
Veness MJ; Harris D
Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484
[TBL] [Abstract][Full Text] [Related]
29. Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients.
Burke MT; Morais C; Oliver KA; Lambie DL; Gobe GC; Carroll RP; Staatz CE; Sinnya S; Soyer HP; Winterford C; Haass NK; Campbell SB; Isbel NM
Am J Clin Pathol; 2015 Apr; 143(4):514-26. PubMed ID: 25780003
[TBL] [Abstract][Full Text] [Related]
30. Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation.
Grimaldi V; Sommese L; Picascia A; Casamassimi A; Cacciatore F; Renda A; De Rosa P; Montesano ML; Sabia C; Fiorito C; De Iorio G; Napoli C
Hum Immunol; 2013 Dec; 74(12):1629-32. PubMed ID: 23974050
[TBL] [Abstract][Full Text] [Related]
31. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
32. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
33. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
[TBL] [Abstract][Full Text] [Related]
34. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
[TBL] [Abstract][Full Text] [Related]
35. Analysis of specificity of anti-human leukocyte antigen antibodies in kidney recipients in reference to clinical outcome.
Nowosiad-Magda M; Myślak M; Roszkowska P; Borowiec-Chłopek Z; Urasińska E; Różański J; Domański L; Ciechanowski K; Giedrys-Kalemba S
Transplant Proc; 2014 Oct; 46(8):2606-12. PubMed ID: 25380877
[TBL] [Abstract][Full Text] [Related]
36. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
Ramsay HM; Harden PN; Reece S; Smith AG; Jones PW; Strange RC; Fryer AA
J Invest Dermatol; 2001 Aug; 117(2):251-5. PubMed ID: 11511301
[TBL] [Abstract][Full Text] [Related]
38. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
39. Nonmelanoma skin cancer after kidney transplant.
Tepeoğlu M; Ayva Ş; Ok Atılgan A; Tunca MZ; Özdemir BH; Moray G; Yıldırım S; Arslan G; Haberal M
Exp Clin Transplant; 2014 Jun; 12(3):233-7. PubMed ID: 24907724
[TBL] [Abstract][Full Text] [Related]
40. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]